In univariate analysis, 12p deletions were strongly linked to early biochemical (PSA) recurrence in all cancers (p < 0.0001, Figure 2a) and there was no difference seen in the prognostic impact of 12p deletions 1, 701 ERG-negative (p < 0.0001, Figure 2b) and 1,578 ERG-positive cancers (p < 0.0001, Figure 2c). The gene discussed is ERG; the disease is cancer.